Key Points
- To examine the kinetic characteristics and structural requirements for fatty acid-induced activation of soluble guanylate cyclase isolated from human platelets.
- Assayed guanylate cyclase activity in cell-free soluble fractions (105,000 × g supernatant) of human platelets treated with Triton X-100 and dithiothreitol at 37 °C.
- Evaluated enzyme kinetics across concentrations of arachidonic acid, structural fatty acid analogs, and prostaglandins, including assessments with aspirin pretreatment.
- Arachidonic acid stimulated soluble guanylate cyclase activity 2- to 3-fold with an activation constant (Ka) of 2.1 µM and a Hill coefficient of 0.98.
- Enzyme activation required a 1,4,7-octatriene structure with an omega-6 double bond, shared by dihomo-gamma-linolenic acid and 22-carbon polyunsaturated fatty acids, while prostaglandins and saturated or monoenoic fatty acids were inactive.
- Activation primarily increased maximal velocity without changing the Mn2+ requirement, and aspirin pretreatment did not impair stimulation, confirming cyclooxygenase independence.
Structured PICO
PPopulationcell-free preparations of human platelets
IInterventionArachidonic acid and other polyunsaturated fatty acids
OOutcomeGuanylate cyclase activitysurrogate
The activity of the soluble form of guanylate cyclase in cell-free preparations of human platelets can be increased by a lipid-protein interaction involving specific polyunsaturated fatty acids like arachidonic acid.